Protalex Inc

(PRTX)

By |

Profile

Protalex Inc is a United States-based clinical stage company. It is primarily focused on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and immune thrombocytopenia.

Contact Information

Website: www.protalex.net
Email: investorrelations@protalex.com
Main Phone: +1 215 862-9720
Address: 131 Columbia Turnpike
Address 2: Suite 1
State: NJ
City / Town: Florham Park
Country: USA
Postal Code: 07932

Issuer Information

Exchange: OTCQB
CEO: Arnold P. Kling
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 0.50 $ 0. (0.00%)
Last Price 0.50 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.50 High 0.50 Low 0.50 Prev Close 0.50
Last Trade Volume 200 52 Wk Hi 3.00 52 Wk Low 0.31
Market Cap 23.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 47,325,387.00 EPS (TTM) -0.17 PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 10 10 10 10
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/02/16 05/02/16 05/02/16 05/02/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1